Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular disease: different strategies for primary and secondary prevention?

× No keyword cloud information.

15 in total

1. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal: Circulation Date: 2003-01-28 Impact factor: 29.690

2. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

Authors: J D Neaton; D Wentworth
Journal: Arch Intern Med Date: 1992-01

3. Mortality in relation to smoking: 40 years' observations on male British doctors.

Authors: R Doll; R Peto; K Wheatley; R Gray; I Sutherland
Journal: BMJ Date: 1994-10-08

4. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

Authors: J Eriksson; J Lindström; T Valle; S Aunola; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; M Lauhkonen; P Lehto; A Lehtonen; A Louheranta; M Mannelin; V Martikkala; M Rastas; J Sundvall; A Turpeinen; T Viljanen; M Uusitupa; J Tuomilehto
Journal: Diabetologia Date: 1999-07 Impact factor: 10.122

5. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors: J D Neaton; H Blackburn; D Jacobs; L Kuller; D J Lee; R Sherwin; J Shih; J Stamler; D Wentworth
Journal: Arch Intern Med Date: 1992-07

6. Smoking cessation guidelines for health professionals: an update. Health Education Authority.

Authors: R West; A McNeill; M Raw
Journal: Thorax Date: 2000-12 Impact factor: 9.139

7. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors:
Journal: BMJ Date: 1994-01-08

8. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.

Authors: S J Pocock; A G Shaper; A N Phillips
Journal: BMJ Date: 1989-04-15

9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

10. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors: S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal: Lancet Date: 1990-03-31 Impact factor: 79.321

26 in total

Review 1. Using Telehealth to Disseminate Primary, Secondary, and Tertiary CVD Interventions to Rural Populations.

Authors: Helene Vilme; Naomi N Duke; Charles Muiruri; LaShawn Wordlaw; Asheley C Skinner
Journal: Curr Hypertens Rep Date: 2019-11-07 Impact factor: 5.369

2. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.

Authors: N Abdel Rida; M I Mohamed Ibrahim; Z U D Babar
Journal: BMC Health Serv Res Date: 2019-12-18 Impact factor: 2.655

3. Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk.

Authors: F El Fakiri; M A Bruijnzeels; A W Hoes
Journal: Heart Date: 2005-10-26 Impact factor: 5.994

Review 4. Yoga for secondary prevention of coronary heart disease.

Authors: Joey S W Kwong; Hoi Lam Caren Lau; Fai Yeung; Pui Hing Chau
Journal: Cochrane Database Syst Rev Date: 2015-07-01

Review 5. Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness.

Authors: Clara Marquina; Ella Zomer; Sandra Vargas-Torres; Sophia Zoungas; Richard Ofori-Asenso; Danny Liew; Zanfina Ademi
Journal: Pharmacoeconomics Date: 2020-10 Impact factor: 4.981

6. Association between 9p21.3 genomic markers and coronary artery disease in East Asians: a meta-analysis involving 9,813 cases and 10,710 controls.

Authors: Jin Guo; Wei Li; Zhenqiang Wu; Xiaoru Cheng; Yang Wang; Tao Chen
Journal: Mol Biol Rep Date: 2012-10-20 Impact factor: 2.316

Cardiovascular disease: different strategies for primary and secondary prevention?